Is ESLAW stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Estrella Immunopharma, 10 years ago, but if you had invested on Monday 2nd of October 2023 when the price was $0.190, you would have made a loss of $-0.0900 per share or -47.37%
No, the average daily trading liquidity for Estrella Immunopharma, is $507 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Estrella Immunopharma, has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Estrella Immunopharma, to be medium [0.6 out of 1]